Acquisition of a Maintenance Contract to cover Illumina’s NextSeq 550, NovaSeq 6000, and the MiSeq sequencers

The National Heart Lung and Blood Institute's Genomic Technology Section seeks to acquire a firm-fixed-price maintenance contract to cover preventative maintenance visits, emergency and non-emergency on-site repair, replacement of certified OEM parts at no additional cost, and software and control support for an Illumina NovaSeq 6000, NextSeq 550, and MiSeq. Quotes for the one-year base period of maintenance support with the potential for four additional one-year option periods will be evaluated based on technical capabilities, personnel and experience, past performance, and price, with award made to the responsible offeror providing the best overall value. Quotes are due by January 19, 2022 and period of performance is from March 1, 2022 to February 28, 2023 for the base period with the option to extend through February 28, 2027.

There is no set-aside designation for this procurement. The maintenance services have a place of performance in Bethesda, MD and involve potential incumbents providing support for the sequencers. The combined synopsis and solicitation does not specify possible award values but seeks a one-year base period of support for the three sequencers with options that could extend the contract through 2027.